Critical illness is a hypercatabolic state. It has been hypothesized that timely and adequate nutrition support may optimize the host response and thereby minimize nutritionally related complications while improving overall outcome. Any illness in due course can lead to a malnourished state-critical illness can worsen this state as patients may become immunocompromised and unable to mount an adequate inflammatory response and therefore susceptible to poor outcomes. Data indicate that prevalence of malnutrition in the ICU ranges from 38% to 78% and is independently associated with poor outcomes. Hence, exploring the role of nutrition as a way to mitigate critical illness is important. In this review, the basic pathophysiology of critical illness and how it alters carbohydrate, protein, and fat metabolism are discussed. This is followed by a discussion of malnutrition and how it affects patient and hospital outcomes. Finally, a summary of the available evidence regarding nutrition support and its impact on outcomes are provided. This review is not intended to provide practice-based guidelines; instead, it intends to highlight available data on the role of nutrition support in critically ill patients. (Nutr Clin Pract. 2019;34:12-22) 
Definition of Critical Illness
Broadly speaking, critical illness is any disease state, medical or surgical, that requires treatment in the intensive care unit (ICU). Although critical illness is frequently associated with infection or sepsis, other conditions such as severe trauma, the postsurgical state, pancreatitis, burn injury, hemorrhage, and ischemia can produce the same clinical findings as microbial invasion, even in the absence of an infectious organism. Hence, these conditions can also fall under the category of critical illness. Sepsis, as defined by American College of Chest Physicians, is a life-threatening organ dysfunction caused by a dysregulated host response to infection. 1 This definition is also used by the Third International Consensus Definitions for Sepsis and Septic Shock published in JAMA in 2016. 2 The systemic inflammatory response syndrome (SIRS) describes the complex pathophysiologic response to an insult such as infection, trauma, burn, pancreatitis, or a variety of other injuries as defined by the American College of Chest Physicians/Society of Critical Care Medicine (SCCM)-sponsored sepsis definitions consensus conference held in 1991. 1 A patient is diagnosed with SIRS if 2 or more of the following are present: temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20 breaths/min or P CO2 <32 mm HG, or a white blood cell count >12,000 mm 3 or <4000 mm 3 .
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Pathophysiology of Critical Illness
Catabolic critical illness is a life-threatening condition created by overwhelming infection, trauma, or other kinds of severe tissue injury (eg, pancreatitis). The defining characteristic of critical illness is the body's inflammatory response, which incites the catabolic response to injury and distinguishes it from the adaptive catabolism characteristic of simple starvation. This series of events is orchestrated by a coordinated neuroendocrine and cytokine response that alters energy expenditure and stimulates dramatic protein catabolism. 3 Initial reaction of the host is at the local site of infection or injury. The reaction begins with cellular activation of macrophages, monocytes, and neutrophils at the level of the vascular endothelium. This is followed by activation of the complement system, leading to vasodilatation and increased capillary permeability, which results in sequestration of interstitial fluids and release of chemoattractants into the local area. Additional macrophages are recruited in the area, which enhances the inflammatory response by phagocytic activity. 4 This response is also supported by 5 Once a high concentration is achieved, the cytokines are released into the systemic circulation and cause the signs and symptoms characteristic of systemic inflammatory response.
The host biologic response to critical illness was initially described by Cuthbertson 6 and expanded upon in subsequent studies by Moore in 1959. 7 The response is broadly categorized into the "ebb phase" and "flow phase" of the postinjury period (Table 1) . These phases broadly define the initial proinflammatory state.
The early ebb phase occurs immediately after insult, can last from 24 to 48 hours, and is characterized by hemodynamic instability with decreased cardiac output and oxygen consumption, low core body temperature, and elevated glucagon, catecholamines, and free fatty acid (FFA) levels. The duration of this phase may be variable depending on the type of insult, initiation of resuscitative measures, and specific treatments to control the primary pathological process. [6] [7] [8] The subsequent, more prolonged flow phase is characterized by an increase in total body oxygen consumption, metabolic rate, cardiac output, and oxidation of fuel sources (carbohydrates, amino acids, and fats). 6, 7 The rise in energy expenditure correlates with the severity of injury. It is minimal in mild injury and may be doubled in severe burn injuries. This phase needs aggressive support in the ICU and management strategies tailored to the etiology of illness.
The increased metabolic demands in critical illness can lead to breakdown of lean body mass, which may contribute to malnutrition. [9] [10] [11] [12] [13] Appropriate nutrition support therapy at this stage may be important for improving outcomes. 3, 14 This systemic "ebb-and-flow" proinflammatory response to infection and tissue damage is the body's mechanism to both fight against infection and provide substrates for healing. 3 However, when this proinflammatory response is severe and overwhelming, it can be harmful to the host. Hence, there is an anti-inflammatory response that counterbalances the proinflammatory response. During this anti-inflammatory response phase, the anti-inflammatory cytokines (IL-4 and IL-10) may predominate rather than proinflammatory cytokines (TNF-α, IL-2, and interferon-γ ). 15 When the balance shifts disproportionately toward an anti-inflammatory state, the weakened immune system is unable to eradicate pathogens and initiate reparative processes as the host becomes increasingly immunocompromised. Thus, there is a delicate balance between proinflammatory and anti-inflammatory phases to facilitate host recovery and have a favorable outcome.
Importantly, nutrition plays a key role in modulating the inflammatory responses, maintaining immune function, slowing skeletal muscle catabolism, promoting tissue repair, 16 and maintaining the gastrointestinal and pulmonary mucosal barrier.
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Pathophysiology in Starvation
In contrast to critical illness, starvation is a hypometabolic state. During starvation, the body systems adapt to using fat as the primary energy source. Initially, the body generates glucose to supply fuel for the nervous system and blood cells. This is achieved during the first 24 hours of starvation by mobilizing glycogen stores from the liver and later glucose produced by hepatic gluconeogenesis from skeletal muscle amino acids, glycerol, and lactate. Fuel for other tissues (eg, heart, kidney, muscle) is sustained by mobilizing fatty acids from adipose tissue. 18 This stage of lipolysis is mainly dependent on a fall in circulating insulin levels, which appears to be the dominant hormone regulating homeostasis during starvation. Lipolysis helps preserve the lean muscle tissue to some extent as the liver converts FFAs to ketone bodies, which are used by brain tissue for metabolism, thereby lessening the need for skeletal muscle amino acids to produce glucose. Central nervous system adaptation to utilizing ketones (so-called ketoadaptation) is a very important adaptive response to starvation, as it spares glucose and muscle protein and helps to preserve muscle and liver glycogen. 18 Other tissues (heart, kidney, muscle) mainly utilize fatty acids, either directly released into circulation from adipose tissue or converted to ketone bodies after partial oxidation in liver. Figure 1 illustrates this process.
Thus, during prolonged starvation, tissues do not utilize large quantities of glucose, which helps prevent the de novo synthesis of glucose (gluconeogenesis) from amino acids and the need for skeletal muscle breakdown to provide the amino acid building blocks. Hence, ketoadaptation is an important mechanism for preserving muscle protein and thus lean body mass. As a consequence, the debilitation of the host during starvation is much slower than that observed during critical illness, during which ketoadaptation is less prominent. During prolonged starvation, the liver can also produce necessary glucose from other substrates, primarily lactate, pyruvate, and glycerol. The release of endogenous catecholamines during fasting is one of the important factors regulating the mobilization of fatty acids from adipose tissue. Fasting stimulates the adrenal medulla and increases the concentration of circulating epinephrine, which enhances the mobilization of gluconeogenic precursors and FFAs. 18, 19 These adaptive mechanisms of starvation are in stark contrast to the fat metabolism during critical illness, during which there is a relative block in fatty acid utilization, and both ketogenesis and ketone body oxidation are suppressed. Hence, tissues depend on carbohydrate and protein as the primary energy source, leading to more rapid development of protein-calorie malnutrition during critical illness compared with simple starvation. (See details in fat metabolism below). The neurohormonal mechanism for this difference in metabolism between critical illness and starvation is not clearly understood.
Changes in Macronutrient Metabolism During Critical Illness
Carbohydrate Metabolism
Hyperglycemia and insulin resistance are common findings in critical illness. 20 Proinflammatory cytokines potentiate the release of catabolic hormones (glucagon, catecholamines, and cortisol). These hormones stimulate glycogenolysis and gluconeogenesis in the liver to mobilize glucose for utilization by tissues and cells that require glucose as their primary energy source. 21 This includes the central nervous system and inflammatory cells. Unfortunately, glycogen stores are depleted within hours, and thus, endogenous fat and protein become the major source of oxidative energy substrate. 22 Protein can be converted to glucose via gluconeogenesis. The glycerol moiety of fat (ie, triacylglycerol) can be used to form glucose. However, the triacyl side chains cannot be converted to glucose, because the human body does not possess the enzymatic machinery necessary for this conversion. Thus, during critical illness, there is large-scale protein degradation in the absence of an exogenous source of glucose. This is necessary to supply fuel for those tissues that preferentially require glucose for energy. Hyperglycemia is also caused by increased endogenous glucose production, decreased glucose uptake, and insulin resistance. 20 
Protein Metabolism
Protein is the main source of energy substrate during the catabolic stress phase of critical illness. The human body does not have any "reserve protein stores," as all protein in the body serves a structural or functional purpose. When protein is used for fuel or other metabolic processes, it is derived from the catabolism of "labile" amino acid sources in skeletal muscle, connective tissue, and the gastrointestinal tract. 23 The protein in skeletal muscle is rapidly metabolized in response to increased demands after injury or acute inflammatory illness. If this phase continues, the net protein catabolism leads to loss of lean body mass and may contribute to organ dysfunction and poor outcome.
The degradation of protein for gluconeogenesis results in increased excretion of nitrogen from the body. One way to monitor the degree of protein loss is to assess "nitrogen balance," which is nitrogen intake in the form of protein minus the amount of nitrogen excreted. As an approximation, 6.25 g of protein contains 1 g of nitrogen. During critical illness, patients are invariably in a net-negative nitrogen balance, meaning nitrogen excretion exceeds nitrogen intake. 24 They remain in generalized net-negative nitrogen balance for variable periods even after the primary pathology is resolved. 22 This may be several months in some cases, such as burn patients. The amino acids released by muscles are directed to the liver, where ureagenesis takes place and synthesis of creatinine, uric acid, and ammonia are all increased. 25 The increased amino acid efflux from peripheral sources provides a substrate for enhanced hepatic gluconeogenesis and positive acute-phase protein synthesis, including haptoglobin and C-reactive protein. 26 There is a decrease in the production of negative acute-phase proteins such as serum albumin and prealbumin, which is why these proteins should not be used as a marker of nutrition status in critical illness. 27 This concept is often known as hepatic reprioritization.
Supplementing adequate amino acids may play an important role during this phase. It does not prevent catabolism completely but can help the host machinery by increasing protein synthesis to offset some of the exaggerated protein catabolism. 28 Studies have shown that patients who receive adequate amino acid support are more likely to survive, as discussed in more detail below. 14 
Fat Metabolism
During the early phase of critical illness, carbohydrate is the preferred energy substrate over fats. 29 Conversion of fat to ATP requires large amounts of oxygen and fully functioning mitochondria, both of which are impaired during stress or injury. 30 Stress hormones (epinephrine, norepinephrine, and glucagon) directly stimulate lipase, leading to hydrolysis of triglycerides stored in adipose tissue, which are then released as FFAs and glycerol into the bloodstream. 31 However, the ability of the cells to transport long-chain FFAs from cytosol to mitochondria is impaired. This can lead to accumulation of FFAs within cells, which can inhibit the function of pyruvate dehydrogenase, leading to accumulation of pyruvate, lactate, and consequently intracellular acidosis. This is a major cause of the decrease in aerobic respiration and the cell's ability to use the Krebs's cycle for energy production. 32, 33 In the later phases of critical illness, the oxidation of FFAs can occur in peripheral tissues, whereas in the liver, they are converted to ketone bodies or reesterified to triglycerides and released into bloodstream as very low-density lipoproteins. Overall metabolism of fats is increased, but complete oxidation can only happen in tissues where mitochondria are functional. 30 
Energy Expenditure
Although hypermetabolism is a typical feature in catabolic critical illness, 34 energy expenditure varies at different stages of illness and with type of illness. 35 Studies have shown that resting energy expenditure (REE) is high during the first week and remains elevated for up to 3 weeks, even when sepsis or other cause of critical illness has been adequately treated. 27 Elevated catecholamine levels influence the metabolic rate and substrate catabolism. Several metabolic pathways are activated, which consume large amounts of energy, including gluconeogenesis, the Cori cycle, and lipolysis. 35 Apart from stress and infection, other factors that increase energy expenditure are fever, pain, respiratory distress, and agitation. After major surgical procedures, such as thoracoabdominal operations, REE usually amounts to 120%-140% of reference values. 36 With severe trauma and complicated medical and surgical infection that require intensive care management, REE can be in the 120%-150% range. 37 The most extensive hypermetabolism is found in patients with major burns (>40% body surface area), in whom REE may reach 140%-160%.
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Malnutrition and Critical Illness
Malnutrition is defined as an acute, subacute, or chronic state of nutrition in which varying degrees of overnutrition or undernutrition, with or without inflammatory state, have led to a change in body composition and diminished function. 39 A consensus statement by the Academy of Nutrition and Dietetics (AND) and the American Society for Parenteral and Enteral Nutrition (ASPEN) was published in 2012, which defined malnutrition as the presence of 2 or more of the following characteristics: insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, localized or generalized fluid accumulation, or decreased functional status. 40 Approximately one-third of patients hospitalized in developed countries have some degree of malnutrition at the time of admission. 41 It is estimated that two-thirds of these patients may experience a further decline without timely nutrition intervention. 9 This can have negative impact on their recovery and may increase risk of complications and readmissions. [9] [10] [11] [12] [13] Also, approximately one-third of patients admitted to the hospital without malnutrition will become malnourished during their hospital stay. 42 In critically ill patients, the range of malnutrition is wide, with prevalence reported from 38% to 78%. 43 Malnutrition worsens outcomes, which is why the high prevalence of malnourished patients is so concerning. For example, Schneider showed that malnutrition is an independent risk factor for nosocomial infections in hospitalized patients. 44 Approximately 2 million nosocomial infections, which are now known as hospital-acquired infections (HAIs), occur annually in the United States. 45 HAIs pose a heavy burden, as these patients are sicker and at higher risk for ICU admissions and mortality. 46 Hence, identifying and managing malnutrition during hospital admission may theoretically help prevent HAIs.
Data from several recent studies show that malnutrition may also influence hospital readmission rates. [47] [48] [49] The largest of these studies, a retrospective observational analysis of >10,000 consecutive admissions, reported a 30-day readmission rate of 17%. 47 Comorbidities that significantly increased the risk of readmission included weight loss (degree of weight loss not defined) and iron-deficiency anemia. Weight loss correlated with a 26% increase in risk of readmission. 47 Evidence also shows that preexisting malnutrition influences postdischarge outcomes, including mortality, readmission rates, and discharge to rehabilitation facilities rather than to home. 12, 50, 51 Finally, it has been demonstrated that early recognition of malnourishment and nutrition intervention in malnourished patients can reduce complications, length of hospital stay, and readmission rates, all of which reduce the overall cost of care.
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Malnutrition Screening in the Obese and Nonobese
The high prevalence of malnutrition in hospitalized patients and its association with poor outcomes and increased costs suggest that the prevention and treatment of this condition can have a high impact. The first step in intervening is recognizing that patients are malnourished or at risk of becoming malnourished. Toward that end, screening for nutrition risk in the ICU helps identify high-risk patients who require aggressive intervention. In the 2016 SCCM-ASPEN critical care guidelines, the use of either the Nutrition Risk in Critically Ill (NUTRIC) Score 43, 53, 54 55 has been recommended as an appropriate screening tool for the ICU setting. 56 The NUTRIC Score (Table 2 ) is designed to quantify the risk of critically ill patients developing adverse events that may be modified by aggressive nutrition therapy. The score, which ranges from 1 to 10, is based on 6 variables defined in Table 2 . The scoring system is shown in Table 3 .
or the Nutrition Risk Screening 2002 (NRS-2002)
Although malnutrition screening tools are important, a comprehensive nutrition assessment is essential to determine the patient's degree of malnutrition. Anthropometric measurements and calculation of body mass index (BMI) may provide information about a patient's nutrition status and risk of complications. For example, a low BMI has been correlated with increased mortality in surgical ICU patients. 57 That being said, it is important to recognize that obese or high-BMI patients can also be malnourished 58 and that a high BMI does not necessarily mean that an individual is well nourished. Unfortunately, data are still lacking about malnutrition in obese patients, and it is not always recognized, which may result in these patients not receiving appropriate nutrition therapy.
Obesity and Critical Illness
The metabolic response to stress and critical illness is very different in obese patients. Contrary to the general belief, obese patients cannot effectively use their most abundant a IL-6 data was shown to contribute very little to the overall prediction of the NUTRIC score, and therefore, it is acceptable to not include it in the score calculation when it is not routinely available. 54 fuel source (ie, fat) and must depend on other fuel sources. 19 These individuals mobilize relatively more protein and less fat compared with nonobese patients because of a relative block both in lipolysis and fat oxidation. This leads to an often-unrecognized degradation of lean body mass with relative preservation of fat mass. Furthermore, overweight patients are prone to insulin resistance. 59 This leads to hyperglycemia with increased risk for infection, which in turn can cause release of inflammatory mediators that further worsen insulin resistance. 20, 60 Thus, it is particularly important to avoid both overfeeding in these patients, which can worsen insulin resistance and hyperglycemia, and undue underfeeding, which can accelerate degradation of lean body mass. 61 Results from various studies elucidate a very diverse obesity-mortality association: increased mortality, 62,63 no effect, 64, 65 and decreased mortality. 66, 67 When malnutrition was not addressed in patient groups, studies showed a protective effect of obesity in critically ill medical and surgical patients. This protective effect of obesity in the past was known as the "obesity paradox." 68 Robinson et al hypothesized that nutrition status of obese patient may have the biggest influence on mortality outcomes. 58 This reiterates what has been shown in earlier studies-that malnutrition can independently increase mortality in many chronic diseases and is true for both the obese and nonobese populations. 12, 50 An important take-home message is that BMI should not be used as an indicator of malnutrition independent of a comprehensive nutrition assessment, as many obese patients can still be malnourished and suffer the consequences of such. 69 The 2016 SCCM-ASPEN critical care guidelines recommend hypocaloric feeding with higher protein provision. 56 The expert panel recommends that for all classes of obesity, energy provision should not exceed >65%-70% of the energy requirements as measured by indirect calorimetry (IC). Mogensen et al conducted a validation study of these recommendations with IC and with other well-known predictive equations 56 and found that the guidelines performed much more reliably when refined based on the degree of obesity. 70 However, further studies are required to determine if permissive hypocaloric feeding with higher protein is beneficial for obese patient population and if it should be the standard of care.
The Impact of Nutrition Support
Although the theoretical importance of nutrition support in the critically ill patient is well established, research demonstrating the importance of nutrition intervention in improving outcome is lacking. The little data that do exist regarding nutrition support therapy in critically ill patients and clinical outcome are conflicting and often inconclusive. This is due to several reasons. First, nutrition intervention studies often have insufficient patient numbers to demonstrate an effect on mortality or other clinical outcomes. That is, the studies are not statistically powered (ie, have a large enough sample size) to demonstrate an effect if one were to exist. Second, nutrition studies that rely on surrogate markers such as improvement in serum prealbumin level, nitrogen balance, and weight do not necessarily correlate with or indicate a cause-effect relationship in improvement of clinical outcome parameters such as infection rates, length of mechanical ventilation, length of hospital or ICU stay, or mortality. Third, nutrition studies are frequently conducted in "ICU" patients. However, ICU patient populations tend to be heterogeneous, and thus, nutrition interventions that may be demonstrably beneficial in some ICU patients may be obscured by lack of effect in other ICU patients with different disease status.
There are other issues that can complicate interpretation of nutrition studies. Many studies exclude malnourished patients, as it seems unethical to deprive feeding to these individuals. However, feeding relatively healthier patients may show minimal quantifiable benefit in outcomes. Moreover, nutrition interventions (EN or parenteral nutrition [PN] ) are often brief, with patients receiving only 5-10 days of intervention. This is a very short time to demonstrate a clinical impact on patient outcomes. Finally, a single nutrient or intervention alone is unlikely to have a major impact on clinical outcome. These are just some of the facts that complicate the ability of investigations to accurately discern the impact of nutrition support therapy on outcomes in the critically ill. This is not to mention the fact that there is a synergistic effect of various other modalities in improving outcomes in critically ill patients in addition to nutrition therapy, such as timely therapeutic medical interventions, good nursing care, and supportive physical therapy. 71 The above being said, there are some findings that can inform nutrition care of the critically ill patients, as discussed below.
Of note, nutrition support therapy is a medical therapy and, if not properly managed, can have adverse effects. One must be careful when trying to provide close to estimated energy and protein needs and keep in mind the risk for adverse outcome from such interventions. For example, a study by Braunschweig et al in which aggressive nutrition intervention was studied in patients with acute lung injury (ALI) was stopped early because of significantly greater mortality in the intervention group. 72 The authors found that the major difference between intervention groups was energy delivery and hypothesized that high energy delivery (25 kcal/kg vs 17 kcal/kg) was harmful. Energy delivery from all sources (including intravenous fluids and fat-based medications such as propofol) should be monitored closely and the nutrition support regimen adjusted accordingly to avoid overfeeding energy. In addition, appropriate monitoring is required to assess fluid balance, glucose variations, insulin requirements, infections, patient tolerance, reflux, and aspiration episodes.
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Protein or Energy Dilemma: Optimization Is the Key
There appears to be an association between overfeeding calories and increased mortality, which has been noted in several studies 53, 72, 75, 76 and elaborated on in review articles 77 and meta-analysis. 78 The precise dividing line between adequate energy provision that improves recovery and excessive energy delivery that may be harmful is not known. There may also be situations when underfeeding calories (eg, in obese individuals) may be beneficial. 56, 61, 70 This is known as hypocaloric, high-protein feeding, which is distinct from permissive underfeeding, which is underfeeding of both calories and protein. For example, Dickerson et al 79 demonstrated that hypocaloric (<20 kcal/kg) highprotein (2 g/kg ideal body weight [IBW]) compared with eucaloric (ࣙ20 kcal/kg) high-protein feeding (2 g/kg IBW) enteral nutrition (EN) in critically ill obese patients led to shorter ICU length of stay, decreased duration of antibiotic therapy, and a trend toward decreased days of mechanical ventilation.
IC is the gold standard for energy estimation, since no single predictive equation accurately estimates energy expenditure. A metabolic cart is used to assess oxygen consumption and carbon dioxide production during a specified time period, which is then used to assess the REE and daily calorie needs. Unfortunately, metabolic carts and the personnel trained to use them are not universally available in various centers and it is also technically difficult to perform. 80 Unlike energy determination, there is no clinically practical way to measure protein needs in the critically ill. Protein needs are therefore estimated theoretically based on ideal, actual, or adjusted body weight measurements. It is known that critically ill patients are often protein deprived, 81 but the exact amount of protein needs is unclear. 82 Meta-analysis 83 and other reviews 84 suggest that highcalorie, low-protein feeding increases complications in patients who are not malnourished. This points to the importance of protein supplementation in this group of patients. Furthermore, data from some observational studies indicate that adequate protein delivery to critically ill patients is associated with decreased length of stay and reduced mortality. 14, 85 Greater protein delivery can improve outcomes, [86] [87] [88] [89] cause fewer infections, 90 and decrease ventilator days. 91 Thus, an effective strategy for some patient populations may be hypocaloric feeding while maintaining ideal protein delivery.
Recent randomized controlled trials (RCTs), including PERMIT trial 92 and EDEN trial, 90 that compared permissive underfeeding of calories with target enteral feedings did not find any statistical difference in mortality. A review of other RCTs suggested that permissive underfeeding or trophic EN with slow ramp-up may be more beneficial than aggressive full feeding in patients with acute respiratory distress syndrome and ALI. 90, [93] [94] [95] These studies show similar effects on clinical outcomes and no statistical difference in mortality rate, length of stay, or duration of mechanical ventilation. Although we do not have strong data about improved mortality outcomes, observational studies have suggested that full enteral feedings are associated with improved outcomes in nutritionally high-risk critically ill patients. 53, 54, 96 This again emphasizes the fact that baseline nutrition status of patients is a strong predictor for clinical outcomes in nutrition studies.
Unfortunately, these results cannot be generalized to all critically ill patients. There are many questions to be answered, including what is optimal nutrition based on nutrition risk; how to individualize energy and protein goals; and what is the appropriate timing, composition, and advancement of energy and protein delivery during the early acute phase of critical illness. Many studies have clearly shown the benefit of high protein delivery during stress states, and these findings suggest that provision of hypocaloric, high-protein feeding with slow advancement may be the optimal strategy in certain patient populations.
Enteral vs Parenteral
Early administration of EN has been shown to reduce infectious complications and decrease length of ICU stay in critical care populations when compared with PN. [97] [98] [99] [100] [101] This is well documented by various RCTs especially in patients with trauma, 102 burns, 103 head injury, 104 major surgery, 105 and acute pancreatitis. 106 That being said, EN may be contraindicated in some individuals, poorly tolerated in others, and sometimes inadequate because of various reasons. Under these conditions, PN should be considered. There are some misconceptions about PN-related complications based on data from older studies 94, [107] [108] [109] in which energy delivery and glucose control were not optimized. However, more recent studies have not shown an increase in infectious complications, which can be attributed to overfeeding avoidance, glucose control, and appropriate central line insertion and care, all of which were not common practices during that time period. 101, [110] [111] [112] [113] Another study that compared early EN vs PN within 48 hours in mechanically ventilated medical ICU patients did not show any difference in ventilator-associated pneumonia, length of stay, or mortality rates but noted that feeding goals can more effectively be attained by PN. 74 Modern-day PN management suggests that the benefits of PN outweigh its risks when EN is not possible for a prolonged period. For example, Heyland found that the use of PN in malnourished ICU patients was associated with significantly fewer overall complications. 114 Similarly, optimizing energy needs by supplementing EN with PN when EN was not well tolerated showed superior outcomes and fewer nosocomial infections. 115, 116 There is a major practice difference in Europe vs the U.S. and Canada in terms of when PN should be initiated. To address the controversy, the Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients (EPaNIC) trial compared early initiation of PN within 48 hours (European guidelines) with late initiation on day 8 (American and Canadian guidelines) in adult patients receiving inadequate EN. 117 They found that the mortality and survival rates were similar in both groups. However, the early PN initiation group had a higher infection rate, greater number of patients who required more days on mechanical ventilation, and increased cost. 118 This suggests that the early institution of PN may not be beneficial and could be harmful. The important practice point is that prolonged starvation should be avoided and that early prophylactic initiation of PN may be harmful. Timing and indication of PN initiation should be considered carefully. Presence of malnutrition and its severity should be considered when making decisions about the type and timing of nutrition support.
Conclusion
Critical illness is a hypercatabolic state and, in the absence of adequate nutrition interventions, can predispose to malnutrition, leading to poor clinical outcomes. The risks associated with malnutrition are well recognized. Most studies agree that effective management of malnutrition may help with overall recovery. However, it is important to identify at-risk patients who are already malnourished or can become malnourished during their critical illness and initiate early intervention. For low-risk patients, the role of nutrition intervention is not clear. In addition, there is a lack of high-quality, well-controlled studies on optimal energy and protein delivery for cases in which nutrition intervention is required. Permissive underfeeding of calories while maintaining full protein delivery may be appropriate in some clinical cases and perhaps beneficial for many critically ill patients early in their clinical course. The impact of malnutrition, timing of initiation of nutrition support therapy, mode of nutrition support therapy, and appropriate targets for energy and protein delivery remain major areas of research in the critically ill population. Understanding the metabolic alterations in critical illness is an important part of evaluating this evolving literature as well as essential to developing and implementing an appropriate nutrition plan for critically ill patients.
